All In Biotech

Drug Trial Radar · NCT02418247

Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

Phase Ⅱ Non-randomized Multicenter Controlled Trial About Effect of Remnant Ablation Therapy on the Recurrence in Low-risk Differentiated Thyroid Cancer Patients

Last checked: Nov 19, 2026Latest source record: Jan 20, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

556

Planned (sponsor's estimate)

Start

May 2013

Primary completion

Dec 2017

Study completion Dec 2020

Sponsor

Lead sponsor
National Cancer Center, KoreaGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Apr 16, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The researchers investigated the rate of biochemical remission in patients without radioactive iodine therapy compared to patients with low dose radioactive iodine treatment in differentiated thyroid cancer patients who underwent total thyroidectomy.

Conditions

  • Thyroid Neoplasms

Interventions

  • I131Drug

  • I123Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Biochemical Remission RateTime frame: within 1 year since first thyroid hormone withdrawal regardless of radioactive iodine administration

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Chungnam National University Hospital

    Daejun, South Korea

  • National Cancer Center, Korea

    Goyang, South Korea

  • Seoul National University Boramae Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Seoul National University Bundang Hospital

    Sungnam, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.